Skip to main content
. 2023 Aug 26;5(5):591–609. doi: 10.1016/j.jaccao.2023.08.001

Figure 6.

Figure 6

Performance of the European Society of Cardiology 0/1-Hour Algorithm With High-Sensitivity Cardiac Troponin I in Patients With and Those Without Cancer

Overall efficacy in patients without cancer was 77.2% and in patients with cancer was 63.1% (P < 0.001). Abbreviations as in Figure 5.